Next Generation Cancer Diagnostics Market Report 2026
Download Free Sample Buy Now
Next Generation Cancer Diagnostics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Next Generation Cancer Diagnostics Market Report 2026

Global Outlook – By Technology (Next-Generation Sequencing (NGS), Lab-On-A-Chip (LOAC) And Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), Circulating Tumor Deoxyribonucleic Acid (ctDNA) Assays, Protein Microarrays, Deoxyribonucleic Acid Microarrays, Other Multi-Omics Platforms), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer), By Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), By Application (Biomarker Development, Circulating Tumor Cell (CTC) Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By End User (Hospitals And Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Next Generation Cancer Diagnostics Market Overview

• Next Generation Cancer Diagnostics market size has reached to $14.4 billion in 2025

• Expected to grow to $26.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%

• Growth Driver: The Rise In Demand For Personalized Medicines Driving The Growth Of The Market Due To Increasing Prevalence Of Chronic And Rare Diseases

• Market Trend: Artificial Intelligence-Powered Multi-Modal Platforms Revolutionize Early Cancer Detection And Personalized Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next Generation Cancer Diagnostics Market?

Next generation cancer diagnostics refers to advanced diagnostic technologies that enable the precise detection, characterization, and monitoring of cancer at the molecular and genetic levels. These diagnostics utilize cutting-edge tools such as genomics, proteomics, and liquid biopsy to provide early detection, personalized treatment planning, and improved patient outcomes.

The main technologies of next generation cancer diagnostics are next-generation sequencing (NGS), q-polymerase chain reaction and multiplexing, lab-on-a-chip (LOAC) and reverse transcriptase-polymerase chain reaction (RT-PCR), circulating tumor deoxyribonucleic acid (ctDNA) assays, protein microarrays, deoxyribonucleic acid microarrays, and others. Next-generation sequencing (NGS) refers to a high-throughput DNA sequencing technology that allows rapid and simultaneous sequencing of millions of DNA fragments, enabling comprehensive analysis of genomes, transcriptomes, and genetic variations. They target various cancer types, including lung cancer, breast cancer, colorectal cancer, and cervical cancer. Their functions include therapeutic monitoring, companion diagnostics, prognostics, cancer screening, and risk analysis. These are applied in biomarker development, circulating tumor cell (CTC) analysis, proteomic analysis, epigenetic analysis, and genetic analysis, and cater to various end users, such as hospitals and clinics, diagnostic laboratories, research and academic institutions, pharmaceutical and biotechnology companies, and home care settings.

Next Generation Cancer Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Next Generation Cancer Diagnostics Market Size and Share 2026?

The next generation cancer diagnostics market size has grown rapidly in recent years. It will grow from $14.4 billion in 2025 to $16.29 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increasing cancer incidence rates, advancements in genomic sequencing technologies, growing clinical adoption of biomarker-based diagnostics, expansion of oncology research funding, rising demand for precision diagnostics.

What Is The Next Generation Cancer Diagnostics Market Growth Forecast?

The next generation cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $26.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising investments in advanced cancer screening programs, growing use of minimally invasive diagnostic methods, expansion of companion diagnostics development, increasing integration of ai-driven clinical decision support. Major trends in the forecast period include increasing adoption of liquid biopsy technologies, rising use of multi-omics diagnostic platforms, growing integration of AI-based cancer analytics, expansion of personalized oncology diagnostics, enhanced focus on early-stage cancer detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Next Generation Cancer Diagnostics Market Segmentation

1) By Technology: Next-Generation Sequencing (NGS), Lab-On-A-Chip (LOAC) And Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), Circulating Tumor Deoxyribonucleic Acid (ctDNA) Assays, Protein Microarrays, Deoxyribonucleic Acid Microarrays, Other Multi-Omics Platforms

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer

3) By Function: Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis

4) By Application: Biomarker Development, Circulating Tumor Cell (CTC) Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutions, Pharmaceutical And Biotechnology Companies, Home Care Settings

Subsegments:

1) By Next-Generation Sequencing: Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Transcriptome Sequencing

2) By Lab-On-A-Chip And Reverse Transcriptase-Polymerase Chain Reaction: Microfluidic Chip Assays, Integrated Reverse Transcriptase-Polymerase Chain Reaction Chips, Point-of-Care Lab-On-A-Chip Devices, High-Throughput Lab-On-A-Chip Systems

3) By Circulating Tumor Deoxyribonucleic Acid Assays: Single-Gene Circulating Tumor Deoxyribonucleic Acid Assays, Multi-Gene Circulating Tumor Deoxyribonucleic Acid Panels, Digital Droplet Circulating Tumor Deoxyribonucleic Acid Assays, Next-Generation Sequencing Circulating Tumor Deoxyribonucleic Acid Assays

4) By Protein Microarrays: Analytical Protein Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays, Antibody-Based Protein Microarrays

5) By Deoxyribonucleic Acid Microarrays: Gene Expression Deoxyribonucleic Acid Microarrays, Single Nucleotide Polymorphism Genotyping Deoxyribonucleic Acid Microarrays, Comparative Genomic Hybridization Deoxyribonucleic Acid Microarrays, Methylation Deoxyribonucleic Acid Microarrays

6) By Other Multi-Omics Platforms: Metabolomics Platforms, Epigenomics Platforms, Transcriptomics Platforms, Integrated Multi-Omics Systems

What Is The Driver Of The Next Generation Cancer Diagnostics Market?

The increasing demand for personalized medicines is expected to propel the growth of the next generation cancer diagnostics market going forward. Personalized medicines refer to medical treatments that are tailored to an individual’s genetic makeup, lifestyle, and environment to ensure the most effective therapy for that specific patient. The increasing demand for personalized medicines is due to the rising prevalence of chronic and rare diseases, which necessitate targeted, patient-specific therapies for more effective treatment outcomes. Next generation cancer diagnostics enable personalized medicine by providing precise molecular insights that guide tailored treatment strategies based on an individual patient’s unique genetic and tumor profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. Therefore, increasing demand for personalized medicines is driving the growth of the next generation cancer diagnostics industry.

Key Players In The Global Next Generation Cancer Diagnostics Market

Major companies operating in the next generation cancer diagnostics market are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Danaher Corporation, Koninklijke Philips N.V., General Electric Company, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Almac Group Ltd., Natera Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Freenome Holdings Inc., Personalis Inc., Burning Rock Biotech Limited., SOPHiA GENETICS S.A., Singlera Genomics Co. Ltd.

Global Next Generation Cancer Diagnostics Market Trends and Insights

Major companies operating in the next generation cancer diagnostics market are focusing on developing innovative solutions such as artificial intelligence-driven multi-modal diagnostic platforms to enhance early detection, personalized treatment, and clinical decision-making. Artificial intelligence-driven multi-modal diagnostic platforms are advanced systems that use artificial intelligence to integrate and analyze multiple types of biological data, such as genomic, proteomic, imaging, and clinical information, to provide more accurate and personalized cancer detection and diagnosis. For instance, in April 2025, OneCell Diagnostics Pvt Ltd., an India-based precision oncology company, launched OncoIncytes, a multi-modal cancer diagnostic platform tailored for precision oncology. The platform combines different types of data, such as circulating tumor DNA, single-cell circulating tumor cells, RNA information, and detailed protein profiles of 150 proteins at the single-cell level. Utilizing a 1080-gene panel powered by AI and machine learning, OncoIncytes delivers highly sensitive and specific insights to enhance clinical trial outcomes, particularly in early-stage research and antibody-drug conjugate development. The platform enables personalized cancer detection, therapy monitoring, and drug development through non-invasive, real-time, and scalable diagnostics, all accessible via OneCell’s proprietary iDiscover application from a CLIA-certified laboratory.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Next Generation Cancer Diagnostics Market?

In June 2023, Quest Diagnostics Inc., a US-based healthcare diagnostics company, acquired Haystack Oncology for an undisclosed amount. With this acquisition, Quest Diagnostics aimed to enhance its technological capabilities in the fast growing minimal residual disease (MRD) liquid biopsy market. Haystack Oncology Inc. is a US-based company that provides next-generation cancer diagnostics through its tumor-informed minimal residual disease (MRD) test, Haystack MRD.

Regional Outlook

North America was the largest region in the next generation cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next Generation Cancer Diagnostics Market?

The next generation cancer diagnostics market consists of revenues earned by entities by providing services such as genomic and molecular profiling, liquid biopsy testing, next-generation sequencing (NGS) services, companion diagnostics development, and bioinformatics and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation cancer diagnostics market also includes sales of gene panels, single-cell analysis systems, nanotechnology-based biosensors, molecular imaging agents, and exosome isolation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Next Generation Cancer Diagnostics Market Report 2026?

The next generation cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next generation cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Next Generation Cancer Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $16.29 billion
Revenue Forecast In 2035 $26.44 billion
Growth Rate CAGR of 13.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Technology, Cancer Type, Function, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Danaher Corporation, Koninklijke Philips N.V., General Electric Company, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Almac Group Ltd., Natera Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Freenome Holdings Inc., Personalis Inc., Burning Rock Biotech Limited., SOPHiA GENETICS S.A., Singlera Genomics Co. Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Next Generation Cancer Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Next Generation Cancer Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Next Generation Cancer Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Next Generation Cancer Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Liquid Biopsy Technologies

4.2.2 Rising Use Of Multi-Omics Diagnostic Platforms

4.2.3 Growing Integration Of Ai-Based Cancer Analytics

4.2.4 Expansion Of Personalized Oncology Diagnostics

4.2.5 Enhanced Focus On Early-Stage Cancer Detection

5. Next Generation Cancer Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Research And Academic Institutions

5.4 Pharmaceutical Companies

5.5 Biotechnology Companies

6. Next Generation Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next Generation Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next Generation Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Next Generation Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Next Generation Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Next Generation Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next Generation Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next Generation Cancer Diagnostics Market Segmentation

9.1. Global Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Next-Generation Sequencing (NGS), Lab-On-A-Chip (LOAC) And Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), Circulating Tumor Deoxyribonucleic Acid (ctDNA) Assays, Protein Microarrays, Deoxyribonucleic Acid Microarrays, Other Multi-Omics Platforms, QPolymerase Chain Reaction And Multiplexing

9.2. Global Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer

9.3. Global Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis

9.4. Global Next Generation Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biomarker Development, Circulating Tumor Cell (CTC) Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis

9.5. Global Next Generation Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutions, Pharmaceutical And Biotechnology Companies, Home Care Settings

9.6. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Transcriptome Sequencing

9.7. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Lab-On-A-Chip And Reverse Transcriptase-Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Microfluidic Chip Assays, Integrated Reverse Transcriptase-Polymerase Chain Reaction Chips, Point-of-Care Lab-On-A-Chip Devices, High-Throughput Lab-On-A-Chip Systems

9.8. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Circulating Tumor Deoxyribonucleic Acid Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Gene Circulating Tumor Deoxyribonucleic Acid Assays, Multi-Gene Circulating Tumor Deoxyribonucleic Acid Panels, Digital Droplet Circulating Tumor Deoxyribonucleic Acid Assays, Next-Generation Sequencing Circulating Tumor Deoxyribonucleic Acid Assays

9.9. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Protein Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Analytical Protein Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays, Antibody-Based Protein Microarrays

9.10. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Deoxyribonucleic Acid Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Expression Deoxyribonucleic Acid Microarrays, Single Nucleotide Polymorphism Genotyping Deoxyribonucleic Acid Microarrays, Comparative Genomic Hybridization Deoxyribonucleic Acid Microarrays, Methylation Deoxyribonucleic Acid Microarrays

9.11. Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Other Multi-Omics Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metabolomics Platforms, Epigenomics Platforms, Transcriptomics Platforms, Integrated Multi-Omics Systems

10. Next Generation Cancer Diagnostics Market Regional And Country Analysis

10.1. Global Next Generation Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Next Generation Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next Generation Cancer Diagnostics Market

11.1. Asia-Pacific Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next Generation Cancer Diagnostics Market

12.1. China Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next Generation Cancer Diagnostics Market

13.1. India Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next Generation Cancer Diagnostics Market

14.1. Japan Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next Generation Cancer Diagnostics Market

15.1. Australia Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next Generation Cancer Diagnostics Market

16.1. Indonesia Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next Generation Cancer Diagnostics Market

17.1. South Korea Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next Generation Cancer Diagnostics Market

18.1. Taiwan Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next Generation Cancer Diagnostics Market

19.1. South East Asia Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next Generation Cancer Diagnostics Market

20.1. Western Europe Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next Generation Cancer Diagnostics Market

21.1. UK Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next Generation Cancer Diagnostics Market

22.1. Germany Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next Generation Cancer Diagnostics Market

23.1. France Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next Generation Cancer Diagnostics Market

24.1. Italy Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next Generation Cancer Diagnostics Market

25.1. Spain Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next Generation Cancer Diagnostics Market

26.1. Eastern Europe Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next Generation Cancer Diagnostics Market

27.1. Russia Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next Generation Cancer Diagnostics Market

28.1. North America Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next Generation Cancer Diagnostics Market

29.1. USA Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next Generation Cancer Diagnostics Market

30.1. Canada Next Generation Cancer Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next Generation Cancer Diagnostics Market

31.1. South America Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next Generation Cancer Diagnostics Market

32.1. Brazil Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next Generation Cancer Diagnostics Market

33.1. Middle East Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next Generation Cancer Diagnostics Market

34.1. Africa Next Generation Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Next Generation Cancer Diagnostics Market, Segmentation By Technology, Segmentation By Cancer Type, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next Generation Cancer Diagnostics Market Regulatory and Investment Landscape

36. Next Generation Cancer Diagnostics Market Competitive Landscape And Company Profiles

36.1. Next Generation Cancer Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Next Generation Cancer Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Next Generation Cancer Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Next Generation Cancer Diagnostics Market Other Major And Innovative Companies

Danaher Corporation, Koninklijke Philips N.V., General Electric Company, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Almac Group Ltd., Natera Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc.

38. Global Next Generation Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next Generation Cancer Diagnostics Market

40. Next Generation Cancer Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Next Generation Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Next Generation Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Next Generation Cancer Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Next Generation Cancer Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Next Generation Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Next Generation Cancer Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Next Generation Cancer Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Next Generation Cancer Diagnostics Market, Major Resource Providers
  • Table 6: Global Next Generation Cancer Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Next Generation Cancer Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Next Generation Cancer Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Next Generation Cancer Diagnostics Market, Major Trends
  • Table 10: Global Next Generation Cancer Diagnostics Market, Major End Users
  • Table 11: Global Next Generation Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Next Generation Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Next Generation Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Next Generation Cancer Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Next Generation Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Next Generation Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Lab-On-A-Chip And Reverse Transcriptase-Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Circulating Tumor Deoxyribonucleic Acid Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Protein Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Deoxyribonucleic Acid Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Other Multi-Omics Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Next Generation Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Next Generation Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Global Next Generation Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 101: Global Next Generation Cancer Diagnostics Market - Company Scoring Matrix
  • Table 102: F. Hoffmann-La Roche AG Financial Performance
  • Table 103: Novartis AG Financial Performance
  • Table 104: Thermo Fisher Scientific Inc. Financial Performance
  • Table 105: Abbott Laboratories Inc. Financial Performance
  • Table 106: Siemens Healthineers AG Financial Performance
  • Table 107: Global Next Generation Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 108: Global Next Generation Cancer Diagnostics Market, Competitive Dashboard
  • Table 109: Global Next Generation Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 110: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 111: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Table 112: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Function, 2025 – 2030

List Of Figures

    Figure 1: Global Next Generation Cancer Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Next Generation Cancer Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Next Generation Cancer Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Next Generation Cancer Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Next Generation Cancer Diagnostics Market, Major Resource Providers
  • Figure 6: Global Next Generation Cancer Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Next Generation Cancer Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Next Generation Cancer Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Next Generation Cancer Diagnostics Market, Major Trends
  • Figure 10: Global Next Generation Cancer Diagnostics Market, Major End Users
  • Figure 11: Global Next Generation Cancer Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Next Generation Cancer Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Next Generation Cancer Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Next Generation Cancer Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Next Generation Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Next Generation Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Lab-On-A-Chip And Reverse Transcriptase-Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Circulating Tumor Deoxyribonucleic Acid Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Protein Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Deoxyribonucleic Acid Microarrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Next Generation Cancer Diagnostics Market, Sub-Segmentation Of Other Multi-Omics Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Next Generation Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Next Generation Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Next Generation Cancer Diagnostics Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Global Next Generation Cancer Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 101: Global Next Generation Cancer Diagnostics Market - Company Scoring Matrix
  • Figure 102: F. Hoffmann-La Roche AG Financial Performance
  • Figure 103: Novartis AG Financial Performance
  • Figure 104: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 105: Abbott Laboratories Inc. Financial Performance
  • Figure 106: Siemens Healthineers AG Financial Performance
  • Figure 107: Global Next Generation Cancer Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 108: Global Next Generation Cancer Diagnostics Market, Competitive Dashboard
  • Figure 109: Global Next Generation Cancer Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 110: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 111: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Figure 112: Global, Next Generation Cancer Diagnostics Market Size Gain ($ Billion), Segmentation By Function, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Next-Generation Gynecological Cancer Diagnostics Market Report 2026 - Global Outlook – By Cancer Type (Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer), By Function (Therapeutic Monitoring,...

Breast Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridizati...

Oncology Companion Diagnostics Market Report 2026 - Global Outlook – By Product (Instrument, Consumables, Software), By Disease Type (Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease T...

Multi Cancer Early Detection Market Report 2026 - Global Outlook – By Type (Liquid Biopsy, Gene Panel, Laboratory Developed Tests (LDT), Other Types), By Cancer Type (Solid Tumors, Hematological Malignancies), By End-Use...

Artificial Intelligence In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, B...

Cancer Tumor Profiling Market Report 2026 - Global Outlook – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Ot...

Skin Cancer Diagnostics Market Report 2026 - Global Outlook – By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types), By Type (Diagnosis, Detection Solutions), By Applicati...

Frequently Asked Questions

The Next Generation Cancer Diagnostics market was valued at $14.4 billion in 2025, increased to $16.29 billion in 2026, and is projected to reach $26.44 billion by 2030.

The global Next Generation Cancer Diagnostics market is expected to grow at a CAGR of 12.9% from 2026 to 2035 to reach $26.44 billion by 2035.

Some Key Players in the Next Generation Cancer Diagnostics market Include, F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Danaher Corporation, Koninklijke Philips N.V., General Electric Company, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Almac Group Ltd., Natera Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Freenome Holdings Inc., Personalis Inc., Burning Rock Biotech Limited., SOPHiA GENETICS S.A., Singlera Genomics Co. Ltd. .

Major trend in this market includes: Artificial Intelligence-Powered Multi-Modal Platforms Revolutionize Early Cancer Detection And Personalized Therapy. For further insights on this market. request a sample here

North America was the largest region in the next generation cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us